Results 101 to 110 of about 675 (153)

Jaundice in an Adult Female Patient With Photosensitivity. [PDF]

ACG Case Rep J
Falcón-Antonio OE, Aguirre-Villarreal D, Martínez-Sánchez FD, García-Juárez I.   +3 more
europepmc   +1 more source

Ανάπτυξη μοριακών δεικτών για την ταυτοποίηση ειδών του γένους Anas [PDF]

, 2010
Κεραμιδιώτη, Ζωή
core  

Fair Funding Decisions: Consistency of the Time Horizons Used in the Calculation of Quality-Adjusted Life Years for Therapies for Very Rare Diseases by the National Institute for Health and Care Excellence in England. [PDF]

Int J Environ Res Public Health
Barman-Aksözen J, Hentschel N, Pettersson M, Schupp E, Granata F, Dechant C, Aksözen MH, Falchetto R.   +7 more
europepmc   +1 more source

Emerging Therapeutic Innovations for Vitiligo Treatment. [PDF]

Curr Issues Mol Biol
Li W, Dong P, Zhang G, Hu J, Yang S.
europepmc   +1 more source

Recent Advances in Management of Vitiligo.

Indian J Dermatol
Das K, Sarkar R, Sinha S.
europepmc   +1 more source

Up-and-Coming Drugs for the Treatment of Vitiligo. [PDF]

Ann Dermatol
Seong SH, Oh SH.
europepmc   +1 more source

How I treat erythropoietic protoporphyria and X-linked protoporphyria.

Blood, 2023
Leaf RK, Dickey AK.
europepmc   +1 more source

Recent Advances in Vitiligo Treatment. [PDF]

Immunotargets Ther
Qiu Y, Su X, Chen J, Jiang S, Tang X, He Y, Liu F.   +6 more
europepmc   +1 more source

A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo. [PDF]

Skin Res Technol
Jafarzadeh A, Pour Mohammad A, Khosravi M, Amiri S, Rasouli A, Keramati H, Goodarzi A.   +6 more
europepmc   +1 more source

Faculty Opinions recommendation of Afamelanotide for erythropoietic protoporphyria.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2017
openaire   +2 more sources